<DOC>
	<DOCNO>NCT02131623</DOCNO>
	<brief_summary>The purpose study validate ItchRO instrument ( clinical outcome assessment measure itch ) prior analysis longitudinal treatment effect data generate ongoing clinical trial .</brief_summary>
	<brief_title>Validation Itch Reported Outcome ( ItchRO ) Diaries Pediatric Cholestatic Liver Disease</brief_title>
	<detailed_description>This research examine psychometric performance electronic diary itch-reported outcome ( ItchRO ) measure patient caregiver stand-alone 2-week validation study target patient population . The study non-interventional nature ; purpose study validate ItchRO prior analysis longitudinal treatment effect data generate ongoing clinical trial . Following train initial completion electronic diary , family return home complete diary twice daily course two week . Additional assessment include numerical rating scale ass itching , patient impression change ( PIC ) , caregiver impression change ( CIC ) , PedsQL ( pediatric quality life ) , child 's sleep habit questionnaire ( CSHQ ) , clinical scratch scale . Longitudinal data use follow natural ( non-interventional ) course disease quality data . Test-retest reliability assess use diary data Day 1 Day 14 stable subject measure PIC child-completed measure CIC caregiver measure . Convergent validity ( correlation ItchRO similar concept measure include study ) also explore ( correlation sleep morning ItchRO diary score ) . Clinical validity ( correlation ItchRO clinician report ) preliminary responsiveness change itch status two week period also assess sample size allow .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Cholestasis</mesh_term>
	<mesh_term>Cholestasis , Intrahepatic</mesh_term>
	<mesh_term>Alagille Syndrome</mesh_term>
	<criteria>Inclusion Criteria subject ALGS PFIC 1 . The subject voluntarily provide verbal assent write assent accordance site 's Institutional Review Board ( IRB ) guideline ; 2 . The subject 's legal guardian voluntarily provide permission study participation authorization access personal health information conjunction HIPPA ; 3 . The subject diagnosis ALGS PFIC ; 4 . The subject able speak comprehend US English ( applicable child age 5 older ) ; 5 . The subject willing able participate twoweek validation study ( applicable child age 5 older ) ; 6 . The subject able understand nature , scope , possible consequence study , and/or present evidence uncooperative attitude ( applicable child age 5 old ) . Inclusion Criteria caregiver subject ALGS PFIC : 1 . The caregiver voluntarily provide write informed consent ; 2 . The caregiver 18 year age old ; 3 . The caregiver serve consistent caregiver subject ALGS PFIC ; 4 . The caregiver 's child subject ALGS PFIC meet study inclusion criterion subject ALGS PFIC ; 5 . The caregiver able speak , read , write , comprehend US English ; 6 . The caregiver willing able participate twoweek validation study ; 7 . The caregiver able understand nature , scope , possible consequence study , and/or present evidence uncooperative attitude .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>